Cargando…

An adaptive power prior for sequential clinical trials – Application to bridging studies

During drug evaluation trials, information from clinical trials previously conducted on another population, indications or schedules may be available. In these cases, it might be desirable to share information by efficiently using the available resources. In this work, we developed an adaptive power...

Descripción completa

Detalles Bibliográficos
Autores principales: Ollier, Adrien, Morita, Satoshi, Ursino, Moreno, Zohar, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433690/
https://www.ncbi.nlm.nih.gov/pubmed/31729275
http://dx.doi.org/10.1177/0962280219886609
_version_ 1783572006004850688
author Ollier, Adrien
Morita, Satoshi
Ursino, Moreno
Zohar, Sarah
author_facet Ollier, Adrien
Morita, Satoshi
Ursino, Moreno
Zohar, Sarah
author_sort Ollier, Adrien
collection PubMed
description During drug evaluation trials, information from clinical trials previously conducted on another population, indications or schedules may be available. In these cases, it might be desirable to share information by efficiently using the available resources. In this work, we developed an adaptive power prior with a commensurability parameter for using historical or external information. It allows, at each stage, full borrowing when the data are not in conflict, no borrowing when the data are in conflict or “tuned” borrowing when the data are in between. We propose to apply our adaptive power prior method to bridging studies between Caucasians and Asians, and we focus on the sequential adaptive allocation design, although other design settings can be used. We weight the prior information in two steps: the effective sample size approach is used to set the maximum desirable amount of information to be shared from historical data at each step of the trial; then, in a sort of Empirical Bayes approach, a commensurability parameter is chosen using a measure of distribution distance. This approach avoids elicitation and computational issues regarding the usual Empirical Bayes approach. We propose several versions of our method, and we conducted an extensive simulation study evaluating the robustness and sensitivity to prior choices.
format Online
Article
Text
id pubmed-7433690
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-74336902020-09-04 An adaptive power prior for sequential clinical trials – Application to bridging studies Ollier, Adrien Morita, Satoshi Ursino, Moreno Zohar, Sarah Stat Methods Med Res Articles During drug evaluation trials, information from clinical trials previously conducted on another population, indications or schedules may be available. In these cases, it might be desirable to share information by efficiently using the available resources. In this work, we developed an adaptive power prior with a commensurability parameter for using historical or external information. It allows, at each stage, full borrowing when the data are not in conflict, no borrowing when the data are in conflict or “tuned” borrowing when the data are in between. We propose to apply our adaptive power prior method to bridging studies between Caucasians and Asians, and we focus on the sequential adaptive allocation design, although other design settings can be used. We weight the prior information in two steps: the effective sample size approach is used to set the maximum desirable amount of information to be shared from historical data at each step of the trial; then, in a sort of Empirical Bayes approach, a commensurability parameter is chosen using a measure of distribution distance. This approach avoids elicitation and computational issues regarding the usual Empirical Bayes approach. We propose several versions of our method, and we conducted an extensive simulation study evaluating the robustness and sensitivity to prior choices. SAGE Publications 2019-11-15 2020-08 /pmc/articles/PMC7433690/ /pubmed/31729275 http://dx.doi.org/10.1177/0962280219886609 Text en © The Author(s) 2019 https://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Articles
Ollier, Adrien
Morita, Satoshi
Ursino, Moreno
Zohar, Sarah
An adaptive power prior for sequential clinical trials – Application to bridging studies
title An adaptive power prior for sequential clinical trials – Application to bridging studies
title_full An adaptive power prior for sequential clinical trials – Application to bridging studies
title_fullStr An adaptive power prior for sequential clinical trials – Application to bridging studies
title_full_unstemmed An adaptive power prior for sequential clinical trials – Application to bridging studies
title_short An adaptive power prior for sequential clinical trials – Application to bridging studies
title_sort adaptive power prior for sequential clinical trials – application to bridging studies
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433690/
https://www.ncbi.nlm.nih.gov/pubmed/31729275
http://dx.doi.org/10.1177/0962280219886609
work_keys_str_mv AT ollieradrien anadaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies
AT moritasatoshi anadaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies
AT ursinomoreno anadaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies
AT zoharsarah anadaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies
AT ollieradrien adaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies
AT moritasatoshi adaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies
AT ursinomoreno adaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies
AT zoharsarah adaptivepowerpriorforsequentialclinicaltrialsapplicationtobridgingstudies